INCY Short Volume

Incyte Corporation (INCY) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $19.74B, listed on NASDAQ, employing roughly 2,617 people, carrying a beta of 0.80 to the broader market. Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. Led by William J. Meury, public since 1993-11-04.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-05-15
Short Volume
433.8K
Total Volume
592.0K
Short %
73.28%
30-Day Avg Short %
68.19%

Showing 30 days of FINRA short volume data for Incyte Corporation.

Learn how short volume is reported and how to read the data →

Frequently asked INCY short volume questions

What is the daily INCY short volume?
As of May 15, 2026, Incyte Corporation (INCY) short volume is 433.8K shares against 592.0K total reported volume, or 73.28% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is INCY short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does INCY short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.